Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

Presentation TCT 2025

Let’s Get Comfortable: Cath Lab Ergonomics and Radiation Safety

Presenter: David G. Rizik

October 25, 2025

Presentation Cardiovascular Interventions 2024

Radiation Protection and Safety in the Cath Lab: Understanding It’s Time to Turn in Our Lead Apron

Presenter: David G. Rizik

November 11, 2024

Presentation ACC 2024

Randomized, Double-blind, Placebo-controlled, Phase 3, Study To Evaluate Lerodalcibep Long-term Efficacy And Safety In Patients With, Or At Very-high Or High Risk, For Cardiovascular Disease On Stable Lipid-lowering Therapy

Presenter: Eric Quinton Klug

April 07, 2024

Presentation Cardiovascular Interventions 2023

Shouldn’t Radiation Safety in the Cath Lab Be Our Top Priority?

Presenter: David G. Rizik

November 10, 2023

Presentation ESC 2021

Cardiovascular Safety of Degarelix versus Leuprolide in Patients with Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial

Presenter: Renato D. Lopes

August 31, 2021

Presentation TCT 2019

TCT 25: Comparative Safety and Effectiveness of Orbital and Rotational Atherectomy in Patients Undergoing Percutaneous Coronary Intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)

Presenter: Devika Aggarwal

September 25, 2019

Presentation Cardiovascular Interventions 2019

Radiation Safety in the Cath Lab

Presenter: David G. Rizik

September 08, 2019

Presentation AHA 2018

Safety and Efficacy of AKCEA-APO(a)-LRx to Lower Lipoprotein(a) Levels in Patients With Established Cardiovascular Disease: A Phase 2 Dose-Ranging Trial

Presenter: Sotirios Tsimikas

November 11, 2018

Presentation Cardiovascular Interventions 2018

Radiation Safety for the Clinical Uses of Flouroscopy

Presenter: Paul S. Teirstein

October 26, 2018

Presentation TCT 2018

TCT-81: The Comparative Effectiveness and Safety of Impella Versus Intra-Aortic Balloon Pump in Patients who Underwent Percutaneous Coronary Intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)

Presenter: Biswajit Kar, Simon Redwood, Devraj Sukul

September 21, 2018

Presentation ACC 2018

Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout and Cardiovascular Disease (The CARES Trial)

Presenter: William B. White

March 11, 2018

Presentation TCT 2017

Special Lunch Lecture: Radiation Safety in the Cath Lab - See Something, Say Something

Presenter: Stephen Balter

October 30, 2017

Presentation TCT 2015

Efficacy and Safety of Novel NovaCross Microcatheter for Chronic Total Occlusions: First-in-Human Study

Presenter: Andrea Abizaid, Daniel Burkhoff, Leszek Bryniarski

October 14, 2015

Advertisement

Let’s Get Comfortable: Cath Lab Ergonomics and Radiation Safety

Radiation Protection and Safety in the Cath Lab: Understanding It’s Time to Turn in Our Lead Apron

Randomized, Double-blind, Placebo-controlled, Phase 3, Study To Evaluate Lerodalcibep Long-term Efficacy And Safety In Patients With, Or At Very-high Or High Risk, For Cardiovascular Disease On Stable Lipid-lowering Therapy

Shouldn’t Radiation Safety in the Cath Lab Be Our Top Priority?

Cardiovascular Safety of Degarelix versus Leuprolide in Patients with Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial

TCT 25: Comparative Safety and Effectiveness of Orbital and Rotational Atherectomy in Patients Undergoing Percutaneous Coronary Intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)

Radiation Safety in the Cath Lab

Safety and Efficacy of AKCEA-APO(a)-LRx to Lower Lipoprotein(a) Levels in Patients With Established Cardiovascular Disease: A Phase 2 Dose-Ranging Trial

Radiation Safety for the Clinical Uses of Flouroscopy

TCT-81: The Comparative Effectiveness and Safety of Impella Versus Intra-Aortic Balloon Pump in Patients who Underwent Percutaneous Coronary Intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)

Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout and Cardiovascular Disease (The CARES Trial)

Special Lunch Lecture: Radiation Safety in the Cath Lab - See Something, Say Something

Efficacy and Safety of Novel NovaCross Microcatheter for Chronic Total Occlusions: First-in-Human Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content